FDA inspection
Boehringer Ingelheim Roxane, Inc.: FDA inspection ending May 9, 2006
FDA inspection 427357 · No Action Indicated (NAI) · Danbury, CT
Key facts
| Inspection ID | 427357 |
|---|---|
| Firm | Boehringer Ingelheim Roxane, Inc. |
| FEI number | 1219767 |
| Address | 175 Briar Ridge Rd |
| City | Danbury |
| State | CT |
| ZIP | 06810-7267 |
| Fiscal year | 2006 |
| Inspection end date | May 9, 2006 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data